Harbor Diversified, Inc. is a development stage pharmaceutical company, which engages in the discovery, development, and commercialization of products for the treatment of diseases related to aging. The firm focuses on two clinical development products, Apoptone and Triolex. The company was founded in November 1992 and is headquartered in Appleton, WI.